Related Experiment Video
Updated: Aug 19, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Mycoses in AIDS
B Dupont1, H H Crewe Brown, K Westermann
1Unité de Mycologie, Institut Pasteur, H pital Necker, Paris, France. bdupont@pasteur.fr
Abstract:
Major changes are occurring in the epidemiology of opportunistic infections (OI) in patients with acquired immune deficiency syndrome (AIDS) and treated with highly active antiretroviral therapy (HAART). A marked decrease of minor and major OI was observed and clinical resistance of thrush to antifungal agents became extremely rare. Primary and secondary prophylaxis against Pneumocystis carinii infections can be stopped; however, the situation is less clear for other OI such as cryptococcosis or endemic mycoses. The epidemiology is dramatically different in the countries which cannot afford the cost of HAART for the majority of patients, such as South Africa. These topics will be discussed in this paper.
Insights
Highly active antiretroviral therapy (HAART) has significantly reduced opportunistic infections (OI) in AIDS patients, making prophylaxis for some infections unnecessary. However, OI epidemiology varies globally, especially in resource-limited settings.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Opportunistic infections (OI) are a major concern in patients with acquired immune deficiency syndrome (AIDS).
- Highly active antiretroviral therapy (HAART) has transformed AIDS management and OI epidemiology.
- Global access to HAART is unequal, leading to disparate OI patterns.
Purpose of the Study:
- To analyze the changing epidemiology of OI in AIDS patients on HAART.
- To evaluate the impact of HAART on OI incidence and antifungal resistance.
- To compare OI epidemiology in high-income versus low-income settings.
Main Methods:
- Review of epidemiological data on OI in AIDS patients.
- Analysis of clinical outcomes related to OI and antifungal resistance.
- Comparative analysis of OI patterns in different healthcare settings.
Main Results:
- A significant decrease in both minor and major OI was observed in patients receiving HAART.
- Clinical resistance of thrush to antifungal agents has become rare.
- Prophylaxis for Pneumocystis carinii pneumonia can be discontinued, but recommendations for other OI remain unclear.
Conclusions:
- HAART has dramatically altered OI epidemiology, reducing their incidence and severity.
- Antifungal resistance in common OI like thrush has decreased with HAART.
- Disparities in HAART access create vastly different OI challenges in various global regions, necessitating tailored public health strategies.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis

